Revvity Launches CE-IVDR T1D Early Detection Solution
WALTHAM, Mass. — September 24, 2026 Revvity, Inc. announced the launch of the GSP® T1D 3plex kit, a fully...
Diagnostics
Advertisement
Intelligent Bio Solutions Completes FDA 510(k) Precision Testing Milestone
NEW YORK, July 21, 2026 Intelligent Bio Solutions Inc. announced the successful completion of precision testing, an important milestone...
AmeriWater Acquires Med Water to Expand Clinical Solutions
DAYTON, Ohio, July 17, 2026 AmeriWater, a leading provider of water purification systems for critical healthcare applications, has announced...
Roche Receives CE Mark for Elecsys IGRA TB Test
BASEL, Switzerland, July 9, 2026 Roche has announced that its Elecsys IGRA TB blood test has received CE Mark...
Roche Presents Phase III Trontinemab Data at AAIC
BASEL, Switzerland, July 7, 2026 Roche announced that it will present extensive new clinical and diagnostic data from its...
Advertisements
GENFIT Secures U.S. Medicare Coverage for NASHnext Diagnostic Test
Lille, France; Cambridge, Massachusetts, United States; and Zurich, Switzerland, July 2, 2026 GENFIT announced that U.S. Medicare has approved...
Castle Biosciences Reports DecisionDx-Melanoma Improves SLNB Risk Prediction
FRIENDSWOOD, Texas, June 25, 2026 Castle Biosciences announced the publication of a prospective multicenter study in Dermatology and Therapy...
Optimi Health Prices $15M Nasdaq Uplisting Offering
VANCOUVER, British Columbia, May 20, 2026 Optimi Health Corp. has announced the pricing of an oversubscribed US$15 million underwritten...
Paragon Institute Proposes Safer Future for AI Medical Devices
BOSTON, Mass., May 20, 2026 The Paragon Institute has released a new scientific proposal highlighting the growing risks associated...
Aidoc Secures $150M Led by Goldman Sachs for AI Growth
NEW YORK, April 29, 2026 Aidoc has announced the successful completion of a $150 million Series E funding round...
Advertisement
